Literature DB >> 25074664

Cancer-specific mortality and competing mortality in patients with head and neck squamous cell carcinoma: a competing risk analysis.

Weidong Shen1, Naoko Sakamoto, Limin Yang.   

Abstract

BACKGROUND: The objective of this study was to estimate probabilities of cancer-specific death and competing death for patients with head and neck squamous cell carcinoma (HNSCC). In addition, we attempted to construct competing risk nomograms to predict prognosis for patients with HNSCC using a large population-based cohort.
METHODS: Patients diagnosed with nonmetastatic HNSCC between 2000 and 2010 were identified from the Surveillance Epidemiology and End Results Program to form the analytic cohort. We estimated cumulative incident function (CIF) of cancer-specific mortality and competing mortality. Nomograms for predicting probability of death were built with proportional subdistribution hazard models.
RESULTS: The study cohort included 23,494 patients with HNSCC. The 5-year CIF for cancer-specific death and competing death were 26.7 % (95 % confidence interval [CI] 26-27.3 %) and 12.7 % (95 % CI 12.2-13.3 %), respectively; 10-year CIF were 32.8 % (95 % CI 31.9-33.6 %) and 23 % (95 % CI 22.1-24 %), respectively. On multivariate analysis, increasing cause-specific mortality was associated with increasing age, increasing tumor size, black race, single status, advanced T and N classifications, and high tumor grade. Increasing probability of competing mortality had a relationship with increasing age, male, black race, single status and nonradiotherapy. Models showed good accuracy with c-index of 0.73 for cause-specific mortality model and 0.69 for competing mortality model.
CONCLUSIONS: We constructed competing risk nomograms for HNSCC using population-based data. The model used for building nomograms represented good performance. These nomograms can serve to guide management of patients with HNSCC.

Entities:  

Mesh:

Year:  2014        PMID: 25074664     DOI: 10.1245/s10434-014-3951-8

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  27 in total

1.  Competing Risk Analysis in Lung Cancer Patients Over 80 Years Old Undergoing Surgery.

Authors:  Haruaki Hino; Takahiro Karasaki; Yukihiro Yoshida; Takeshi Fukami; Atsushi Sano; Makoto Tanaka; Yoshiaki Furuhata; Kosuke Kashiwabara; Junji Ichinose; Mitsuaki Kawashima; Jun Nakajima
Journal:  World J Surg       Date:  2019-07       Impact factor: 3.352

2.  Investigating Patient and Physician Delays in the Diagnosis of Head and Neck Cancers: a Canadian Perspective.

Authors:  Jonghun John Lee; Chris Dhepnorrarat; Joyce Nyhof-Young; Ian Witterick
Journal:  J Cancer Educ       Date:  2016-03       Impact factor: 2.037

3.  Adverse respiratory outcomes among head and neck cancer survivors in the Utah Cancer Survivors Study.

Authors:  Daisuke Kawakita; Sarah Abdelaziz; Yuji Chen; Kerry Rowe; John Snyder; Alison Fraser; Ken Smith; Kimberly Herget; Vikrant Deshmukh; Michael Newman; Marcus Monroe; Mia Hashibe
Journal:  Cancer       Date:  2019-11-13       Impact factor: 6.860

4.  Association of periodontitis and human papillomavirus in oral rinse specimens: Results from the National Health and Nutrition Survey 2009-2012.

Authors:  R Constance Wiener; Usha Sambamoorthi; Richard J Jurevic
Journal:  J Am Dent Assoc       Date:  2015-06       Impact factor: 3.634

5.  Age-adjusted comorbidity and survival in locally advanced laryngeal cancer.

Authors:  Collin F Mulcahy; Abdallah S R Mohamed; Aasheesh Kanwar; Katherine A Hutcheson; Alokananda Ghosh; David Vock; Randal S Weber; Stephen Y Lai; Gary Brandon Gunn; Mark Zafereo; William H Morrison; Renata Ferrarotto; Adam S Garden; David I Rosenthal; Clifton D Fuller
Journal:  Head Neck       Date:  2018-05-13       Impact factor: 3.147

6.  Melanoma-specific mortality and competing mortality in patients with non-metastatic malignant melanoma: a population-based analysis.

Authors:  Weidong Shen; Naoko Sakamoto; Limin Yang
Journal:  BMC Cancer       Date:  2016-07-07       Impact factor: 4.430

7.  Nomograms predicting long-term overall survival and cancer-specific survival in head and neck squamous cell carcinoma patients.

Authors:  Jun Ju; Jia Wang; Chao Ma; Yun Li; Zhenyan Zhao; Tao Gao; Qianwei Ni; Moyi Sun
Journal:  Oncotarget       Date:  2016-08-09

8.  Oral squamous cell carcinoma patients can be differentiated from healthy individuals with label-free serum proteomics.

Authors:  Mayank Saraswat; Antti Mäkitie; Rahul Agarwal; Sakari Joenväärä; Suvi Renkonen
Journal:  Br J Cancer       Date:  2017-06-20       Impact factor: 7.640

9.  MiR-223-3p inhibits angiogenesis and promotes resistance to cetuximab in head and neck squamous cell carcinoma.

Authors:  Paul Hofman; Valérie Vouret-Craviari; Alexandre Bozec; Joséphine Zangari; Mathilde Butori-Pepino; Marius Ilie; Salomé Lalvee; Thierry Juhel; Catherine Butori; Patrick Brest
Journal:  Oncotarget       Date:  2017-07-11

10.  Nomogram for predicting survival in patients with pancreatic cancer.

Authors:  Wei Song; Dong-Liu Miao; Lei Chen
Journal:  Onco Targets Ther       Date:  2018-01-24       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.